These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3784036)

  • 1. [Relation between various autoimmune antibodies and serum complement levels in patients with systemic lupus erythematosus].
    Okumura N; Kumagai T; Kameko M; Kanai M
    Rinsho Byori; 1986 Aug; 34(8):967-72. PubMed ID: 3784036
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical observations on C3 and CH50 in the serum of patients with systemic lupus erythematosus].
    Jin A
    Zhonghua Yi Xue Za Zhi; 1984 Jan; 64(1):36-8. PubMed ID: 6430492
    [No Abstract]   [Full Text] [Related]  

  • 3. [The significance of immuno-biologic parameters during and in the prognosis of patients with systemic lupus erythematosus].
    Ljaljević M; Ljaljević J; Zlatković Lj; Latković J
    Glas Srp Akad Nauka Med; 1982; (35):111-20. PubMed ID: 7182242
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biological diagnosis of systemic lupus erythematosus].
    Hilliquin P; Weill BJ
    Ann Med Interne (Paris); 1991; 142(7):515-20. PubMed ID: 1789530
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relation between immune complexes, anti-DNA antibodies and complement in lupus nephropathy].
    Pastore A; Manno C; Losuriello V; Vox E; Schena FP
    Minerva Nefrol; 1981; 28(4):503-8. PubMed ID: 7339520
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antinuclear factor, phenomena of the LE cells and complement in systemic erythematosus].
    Okuda M
    Nihon Rinsho; 1968 Dec; 26(12):3438-48. PubMed ID: 4181083
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum complement levels in systemic lupus erythematosus].
    Morita M; Nishishita S; Amano T; Ofuji T
    Arerugi; 1971 Mar; 20(3):159-68. PubMed ID: 4101817
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current viewpoints on the pathogenesis of lupus erythematosus].
    Sönnichsen N; Haustein UF; Barthelmes H
    Z Arztl Fortbild (Jena); 1971 Jun; 65(12):581-5. PubMed ID: 4939579
    [No Abstract]   [Full Text] [Related]  

  • 9. [Case of systemic lupus erythematosus associated with disseminated intravascular coagulation (DIC); with special reference to the relation between autoimmune phenomena and coagulation-fibrinolysis reactions].
    Shinmyozu K; Ichinose A; Okada A; Maruyama I; Igata A
    Nihon Naika Gakkai Zasshi; 1983 Jul; 72(7):947-54. PubMed ID: 6663182
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunopathologic reactions in systemic lupus erythematosus and rheumatoid arthritis].
    Tarasenko RV
    Vrach Delo; 1974 Feb; (2):24-7. PubMed ID: 4468615
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical features of systemic lupus erythematosus patients with antihistone antibodies.
    Fritzler M; Ryan P; Kinsella TD
    J Rheumatol; 1982; 9(1):46-51. PubMed ID: 7086779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of complement by autoimmune antibodies isolated from sera of patients with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
    Daha MR; Van Es LA
    Neth J Med; 1982; 25(7):202-7. PubMed ID: 6924073
    [No Abstract]   [Full Text] [Related]  

  • 13. Levamisole in the treatment of systemic lupus erythematosus--preliminary results.
    Feng PH; Oon CJ; Yo SL; Lau YK
    Singapore Med J; 1978 Sep; 19(3):120-4. PubMed ID: 751195
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum immunoconglutinins and complement in systemic lupus erythematosus.
    Casali P; Scevola M
    Experientia; 1976 Dec; 32(12):1596-7. PubMed ID: 1021462
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of selected immunological parameters in the diagnosis and follow-up of systemic lupus erythematosus].
    Wollina U; Knopf B; Koch HJ
    Rev Med Chir Soc Med Nat Iasi; 1984; 88(4):697-700. PubMed ID: 6537639
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fluctuation of serum complement activities in systemic lupus erythematosus and its clinical significance].
    Okuda M
    Naika; 1970 Feb; 25(2):353-8. PubMed ID: 5309587
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS
    Vestn Dermatol Venerol; 1980 Nov; (11):17-22. PubMed ID: 7003977
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythrosedimentation and serum complement as parameters of clinical activity in systemic lupus erythematosus.
    Rivero I; Moravenik M; Diumenjo MS; Vannucci J
    Rev Clin Esp; 1977 Dec; 147(5):495-8. PubMed ID: 605255
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical importance of investigations of completed and incompleted phagocytosis and the level of serum complement as indicators of nonspecific immunological reactivity of patients with systemic lupus erythematosus].
    Ivanova AV; Selivanova IA; Poroshina NS; Gagarina LN
    Vopr Revm; 1973; 13(2):51-2. PubMed ID: 4772875
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.